-
公开(公告)号:WO2006127588A3
公开(公告)日:2007-07-26
申请号:PCT/US2006019712
申请日:2006-05-22
Applicant: VERTEX PHARMA , HADIDA RUAH SARA S , HAZLEWOOD ANNA R , GROOTENHUIS PETER D J , SINGH ASHVANI K , CLEVELAND THOMAS , VAN GOOR FREDERICK F
Inventor: HADIDA RUAH SARA S , HAZLEWOOD ANNA R , GROOTENHUIS PETER D J , SINGH ASHVANI K , CLEVELAND THOMAS , VAN GOOR FREDERICK F
IPC: C07D239/42 , A61K31/505 , A61K31/506 , C07D403/04 , C07D403/14 , C07D405/12 , C07D405/14 , C07D409/04 , C07D409/14 , C07D491/10
CPC classification number: C07D405/12 , C07D239/42 , C07D403/02 , C07D403/04 , C07D403/14 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/02 , C07D417/02 , C07D491/10
Abstract: 4-amido-pyrimidine compounds, derivatives and compositions thereof, and synthetic methods described herein are useful for modulating ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"). The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
Abstract translation: 4-氨基 - 嘧啶化合物,其衍生物和组合物以及本文所述的合成方法可用于调节ATP结合盒(“ABC”)转运蛋白或其片段,包括囊性纤维化跨膜电导调节剂(“CFTR”)。 本发明还涉及使用这种调节剂治疗ABC转运蛋白介导的疾病的方法。
-
公开(公告)号:WO2006002421A3
公开(公告)日:2006-09-21
申请号:PCT/US2005022768
申请日:2005-06-24
Applicant: VERTEX PHARMA , HADIDA RUAH SARAH S , HAZLEWOOD ANNA R , GROOTENHUIS PETER D J , VAN GOOR FREDERICK F , SINGH ASHVANI K , ZHOU JINGLAN , MCCARTNEY JASON
Inventor: HADIDA RUAH SARAH S , HAZLEWOOD ANNA R , GROOTENHUIS PETER D J , VAN GOOR FREDERICK F , SINGH ASHVANI K , ZHOU JINGLAN , MCCARTNEY JASON
IPC: C07D401/12 , A61K31/47 , A61K31/4709 , A61P25/00 , A61P31/00 , C07C215/76 , C07D209/08 , C07D209/12 , C07D209/14 , C07D209/18 , C07D215/56 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12
CPC classification number: C07D471/10 , A61K8/4926 , A61K31/04 , A61K31/136 , A61K31/265 , A61K31/27 , A61K31/277 , A61K31/352 , A61K31/403 , A61K31/404 , A61K31/4045 , A61K31/44 , A61K31/47 , A61K31/4709 , A61K31/472 , A61K31/4747 , A61K31/538 , A61K31/5415 , A61K31/55 , A61K45/06 , C07C205/11 , C07C205/58 , C07C209/00 , C07C211/17 , C07C211/50 , C07C211/52 , C07C215/28 , C07C215/70 , C07C215/76 , C07C215/78 , C07C217/76 , C07C217/80 , C07C217/84 , C07C219/34 , C07C229/52 , C07C255/58 , C07C271/20 , C07C311/08 , C07C311/39 , C07C2601/14 , C07C2601/18 , C07C2602/10 , C07C2603/74 , C07D209/04 , C07D209/08 , C07D209/12 , C07D209/14 , C07D209/18 , C07D209/20 , C07D209/42 , C07D209/94 , C07D209/96 , C07D213/20 , C07D213/73 , C07D215/227 , C07D215/233 , C07D215/38 , C07D215/56 , C07D217/04 , C07D217/06 , C07D223/16 , C07D265/36 , C07D279/16 , C07D311/58 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , G01N33/48728 , G01N33/5035 , G01N33/566 , G01N33/6872 , G01N2333/705
Abstract: The present invention relates to modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
Abstract translation: 本发明涉及ATP结合盒(“ABC”)转运蛋白或其片段的调节剂,包括囊性纤维化跨膜电导调节剂,其组合物及其方法。 本发明还涉及使用这种调节剂治疗ABC转运蛋白介导的疾病的方法。
-
3.4-OXO-1H-QUINOLINE-3-CARBOXAMIDES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS 审中-公开
Title translation: 作为ATP结合蛋白转运蛋白的调节剂的4-OXO-1H-喹啉-3-羧酰胺公开(公告)号:WO2011072241A9
公开(公告)日:2012-06-14
申请号:PCT/US2010059920
申请日:2010-12-10
Applicant: VERTEX PHARMA , SHETH URVI , FANNING LEV T D , NUMA MEHDI , BINCH HAYLEY , HURLEY DENNIS JAMES , ZHOU JINGLAN , HADIDA RUAH SARA S , HAZLEWOOD ANNA R , SILINA ALINA , VAIRAGOUNDAR RAJENDRAN , VAN GOOR FREDRICK F , GROOTENHUIS PETER DIEDERIK JAN , BOTFIELD MARTYN C
Inventor: SHETH URVI , FANNING LEV T D , NUMA MEHDI , BINCH HAYLEY , HURLEY DENNIS JAMES , ZHOU JINGLAN , HADIDA RUAH SARA S , HAZLEWOOD ANNA R , SILINA ALINA , VAIRAGOUNDAR RAJENDRAN , VAN GOOR FREDRICK F , GROOTENHUIS PETER DIEDERIK JAN , BOTFIELD MARTYN C
IPC: C07D215/56 , A61K31/4709 , A61P11/00 , C07D401/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/08
CPC classification number: C07C215/76 , C07D209/08 , C07D209/14 , C07D209/18 , C07D209/42 , C07D209/94 , C07D213/20 , C07D213/73 , C07D215/227 , C07D215/38 , C07D215/56 , C07D217/06 , C07D223/16 , C07D265/36 , C07D279/16 , C07D311/58 , C07D401/12 , C07D401/14 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/10
Abstract: The present invention relates to 4-oxo-1H-quinoline-3-carboxamides as modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
Abstract translation: 本发明涉及作为ATP结合盒(“ABC”)转运体或其片段的调节剂的4-氧代-1H-喹啉-3-甲酰胺,包括囊性纤维化跨膜电导调节剂,其组合物及其方法。 本发明还涉及使用这种调节剂治疗ABC转运蛋白介导的疾病的方法。
-
公开(公告)号:WO2006099256A3
公开(公告)日:2006-12-07
申请号:PCT/US2006008825
申请日:2006-03-13
Applicant: VERTEX PHARMA , HADIDA RUAH SARA , HAZLEWOOD ANNA R , GROOTENHUIS PETER D J , ZHOU JINGLAN
Inventor: HADIDA RUAH SARA , HAZLEWOOD ANNA R , GROOTENHUIS PETER D J , ZHOU JINGLAN
IPC: A61K31/404 , A61K31/435 , A61K31/44 , A61K31/4453 , A61K31/496 , A61P43/00 , C07D209/04 , C07D209/12 , C07D209/18 , C07D209/42 , C07D401/02 , C07D401/12 , C07D403/02 , C07D403/12
CPC classification number: C07D209/20 , A61K31/404 , A61K31/4439 , A61K31/454 , A61K31/4725 , A61K31/496 , C07D209/18 , C07D401/12 , C07D403/12
Abstract: The present invention relates to modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
Abstract translation: 本发明涉及ATP结合盒(“ABC”)转运体或其片段的调节剂,包括囊性纤维化跨膜电导调节剂(“CFTR”),其组合物及其方法。 本发明还涉及使用这种调节剂治疗ABC转运蛋白介导的疾病的方法。
-
公开(公告)号:CA2881078C
公开(公告)日:2018-10-02
申请号:CA2881078
申请日:2005-06-24
Applicant: VERTEX PHARMA
Inventor: HADIDA-RUAH SARA S , HAZLEWOOD ANNA R , GROOTENHUIS PETER D J , VAN GOOR FREDRICK F , SINGH ASHVANI K , ZHOU JINGLAN , MCCARTNEY JASON
IPC: C07C215/76 , C07C68/00 , C07C201/14 , C07C213/02 , C07D215/56
Abstract: The present invention relates to a compound having formula A-I: (see formula A-I); wherein G1, G2 and G3 are as described herein, and processes for making such compounds.
-
公开(公告)号:HRP20180300T1
公开(公告)日:2018-04-20
申请号:HRP20180300
申请日:2018-02-19
Applicant: VERTEX PHARMA
Inventor: HADIDA-RUAH SARA SABINA , HAZLEWOOD ANNA R , GROOTENHUIS PETER D J , VAN GOOR FREDRICK F , SINGH ASHVANI K , ZHOU JINGLAN , MCCARTNEY JASON
IPC: C07D215/56 , A61K31/47 , A61P11/08 , A61P29/00 , A61P31/00
-
公开(公告)号:LT2489659T
公开(公告)日:2018-03-26
申请号:LT12152224
申请日:2005-06-24
Applicant: VERTEX PHARMA
Inventor: HADIDA RUAH SARAH S , HAZLEWOOD ANNA R , GROOTENHUIS PETER D J , VAN GOOR FREDRICK F , SINGH ASHVANI K , ZHOU JINGLAN , MCCARTNEY JASON
IPC: C07D215/56 , A61K31/47 , A61P11/08 , A61P29/00 , A61P31/00
-
公开(公告)号:PL2502911T3
公开(公告)日:2017-09-29
申请号:PL12152225
申请日:2005-06-24
Applicant: VERTEX PHARMA
Inventor: HADIDA RUAH SARAH S , HAZLEWOOD ANNA R , GROOTENHUIS PETER D J , VAN GOOR FREDRICK F , SINGH ASHVANI K , ZHOU JINGLAN , MCCARTNEY JASON
IPC: C07D401/12 , A61K31/47 , A61K31/4709 , A61P25/00 , A61P31/00 , A61P35/00 , C07C215/76 , C07D209/08 , C07D209/12 , C07D209/14 , C07D209/18 , C07D215/56 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12
-
公开(公告)号:LT2502911T
公开(公告)日:2017-09-11
申请号:LT12152225
申请日:2005-06-24
Applicant: VERTEX PHARMA
Inventor: HADIDA RUAH SARAH S , HAZLEWOOD ANNA R , GROOTENHUIS PETER D J , VAN GOOR FREDRICK F , SINGH ASHVANI K , ZHOU JINGLAN , MCCARTNEY JASON
IPC: C07D401/12 , A61K31/47 , A61K31/4709 , A61P25/00 , A61P31/00 , A61P35/00 , C07C215/76 , C07D209/08 , C07D209/12 , C07D209/14 , C07D209/18 , C07D215/56 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12
-
公开(公告)号:PT1773816E
公开(公告)日:2015-04-29
申请号:PT05791060
申请日:2005-06-24
Applicant: VERTEX PHARMA
-
-
-
-
-
-
-
-
-